x

Coronavirus

Sri Lanka Received 728,460 Doses of AstraZeneca

COLOMBO, Sri Lanka — Sri Lanka received 728,460 doses of AstraZeneca from the COVAX program on Saturday.

The consignment was flown as part of the total contribution of more than 1.4 million doses provided by Japan through the COVAX’s dose sharing, said UNICEF in a statement.

The Health Ministry says part of the doses will be used to give the second doses.

This is the third consignment of COVID vaccines received by Sri Lanka under the COVAX Facility. The first delivery was 264,000 doses of AstraZeneca in March, followed by 1.5 million Moderna vaccines in July.

The country has been facing a shortage more than 500,000 doses of AstraZeneca vaccine after the producer in the neighboring India failed to deliver the promised shots because of the surge of the virus in India.

Sri Lanka has registered 306,662 cases and 4,380 deaths.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

Mission, TNH’s New Travel Documentary Series with Clelia Charissis

Every weekend, TNH and Clelia Charissis are on a mission, traveling around Greece and the world to highlight places through the people we meet along the way.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.